NaturalShrimp (SHMP) Action Cours

NaturalShrimp, Inc. is a biotechnology company, which engages in the development and production of gourmet-grade shrimp without the use of antibiotics, probiotics, or toxic chemicals. The company is headquartered in Dallas, Texas and currently employs 28 full-time employees. The company went IPO on 2010-08-03. The firm has developed a commercially viable system for growing shrimp in enclosed salt-water systems using technology to produce fresh, naturally grown shrimp, without the use of antibiotics or toxic chemicals. Its systems can be located anywhere to produce gourmet-grade Pacific white shrimp. Its Vibrio Suppression technology utilizes electrocoagulation (a procedure that uses heat from an electric current to destroy abnormal tissue) to kill potential pathogens and harmful bacteria, such as vibrio. The firm's technology platforms combine electrocoagulation and Hydrogas. The electrocoagulation system replaces the need for biofilters and instead applies non-biological, electrical processes and uses electronics to remove ammonia and to control the level of pathogens in an aquaculture system. Its subsidiaries include NaturalShrimp USA Corporation, NaturalShrimp Global, Inc., and Natural Aquatic Systems, Inc.